Exxon Signs Preliminary Agreement with Venezuela to Evaluate Oil Opportunities
📊 XOM — Piyasa Yorumu
▲ up · 55%XOM shares declined 2.5% over the past 24 hours to 164.73, with the RSI at 31.5 approaching oversold territory, raising the likelihood of a short-term rebound. Although the MACD remains in negative territory, it is trading above its signal line, indicating that downside momentum is weakening. A preliminary agreement signed with Venezuela offers long-term growth potential for Exxon, but no concrete production or revenue impact is expected in the near term; the news may mainly provide sentiment support. With the price below the SMA20 and SMA50, the technical picture remains weak, so any bullish signal should be treated with caution. A mild recovery is possible over a 1-3 day horizon given the news's limited positive effect, but additional confirmation is needed for a sustained trend reversal.
📊 GOOGL — Piyasa Yorumu
■ neutral · 30%The news focuses on Exxon and Venezuelan oil and has no direct connection to GOOGL; therefore, its impact on the stock will likely be limited. Technical indicators present a mixed picture: the price is slightly above the 20- and 50-day moving averages, the MACD is above its signal line, and the RSI is around 50, a neutral level. Although the 1.2% decline over the past 24 hours points to short-term weakness, there is no clear trend signal. Since the news has no sectoral link, the direction for GOOGL remains uncertain. In the short term, sideways movement or slight fluctuation can be expected.
📊 CVX — Piyasa Yorumu
■ neutral · 55%The news centers on Exxon (XOM); its direct impact on CVX is limited and indirect. CVX's technical picture is weak: the price is below SMA20 and SMA50, MACD is in negative territory but slightly above its signal line, and RSI14 at ~30.7 is near oversold. While this combination raises the possibility of limited rebound buying in the short term, the trend remains downward. Geopolitical/supply news originating from Venezuela may slightly support sector sentiment, but it is not a clear catalyst for CVX. For 1-3 days, I expect a neutral, mildly recovery-prone but fragile outlook.